Erythromycin resistance in viridans streptococci bacteremia is clinically significant.

Grey, Eva; Mraz, Marianna; Docze, Andrea; Korcova, Jarmila; Bucko, Eva; Krcmery, Vladimir

Grey, Eva; Mraz, Marianna; Docze, Andrea; Korcova, Jarmila; Bucko, Eva; Krcmery, Vladimir.

Chemotherapy ; 53(1): 42-3, 2007.

Article in En | MEDLINE | ID: mdl-17202810

Subject(s)

Anti-Bacterial Agents/pharmacology; Bacteremia/microbiology; Drug Resistance, Bacterial; Erythromycin/pharmacology; Viridans Streptococci/drug effects; Anti-Bacterial Agents/therapeutic use; Bacteremia/drug therapy; Erythromycin/therapeutic use; Humans; Penicillin Resistance; Risk Factors; Treatment Outcome; Viridans Streptococci/isolation & purification

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Erythromycin / Bacteremia / Drug Resistance, Bacterial / Viridans Streptococci / Anti-Bacterial Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Chemotherapy Year: 2007 Document type: Article Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links